DYAI
DYAI
NASDAQ · Biotechnology

Dyadic International Inc

$0.35
-0.04 (-9.77%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +9,223.1% upside
Low Target $20.70
Average Target $32.64
High Target $34.69
Current Price $0.35
Current
$0.35
Target
$32.64
$20.70 $32.64 avg $34.69
Scenario Analysis
Bear Case
$20.70
5,812.6%
Low target
Base Case
$32.64
+9,223.1%
Avg target
Bull Case
$34.69
+9,808.6%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.60
-78.1% from high
52-Week Low
$0.34
+2.9% from low
Target vs 52W High
$32.64
+1,940.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%